Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
AssigneeCel-Sci Corporation
InventorsDaniel H. Zimmerman, Donald A. Elliott
Life of this patent
Estimating the term…
Abstract
The present invention relates to a heterofunctional cellular immunological reagent comprising at least two T cell specific binding ligands covalently linked together, wherein one of the T cell specific binding ligands binds to a specific class or subclass of T cells and another of the T cell specific binding ligands is an antigen associated with disease or a causative agent of disease, or epitope thereof. The present invention also relates to vaccines containing the heterofunctional cellular immunological reagents and methods for the use of the same.
Claims5
A heterofunctional cellular immunological product comprising at least two T cell specific binding ligands covalently linked together,
- wherein the T cell specific binding ligands are derived from different molecules, and
- wherein one of said T cell specific binding ligands is a peptide which binds to a specific class or subclass of T cells selected from the group consisting of helper T cells, suppressor T cells and cytotoxic T cells and modulates T cell activity,
- wherein when said T cell specific binding ligand which binds to a specific class or subclass of T cells is derived from an MHC molecule, such consists of the non-polymorphic region of the MHC molecule;
- and
- another of said T cell specific binding ligands is an antigenic peptide associated with disease or a causative agent of disease, or an epitope thereof, and
- wherein said product is about 20 to 100 amino acids in length.
Dependencies are inferred from the claim text.